You, Hong

Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis

Chen, W., Yang, A., Jia, J., Popov, Y. V., Schuppan, D., & You, H. (2020) · Hepatology

Liver physiology and pathologyInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 284

Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis

Yang, A.-T., Kim, Y.-O., Yan, X.-Z., Abe, H., Aslam, M., Park, K.-S., Zhao, X.-Y., Jia, J.-D., Klein, T., You, H., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology

Liver physiology and pathologyPeptidase Inhibition and Analysis

Cited by 144

APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis

You, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 133

Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice

Cong, M., Zhao, W., Liu, T., Wang, P., Fan, X., Zhai, Q., Bao, X., Zhang, D., You, H., Kisseleva, T., et al. (2017) · International Journal of Molecular Medicine

Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Cited by 33

Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities

Chen, W., Sun, Y., Chen, S., Ge, X., Zhang, W., Zhang, N., Wu, X., Song, Z., Han, H., Desert, R., et al. (2023) · Hepatology

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 30

A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China

Zhang, W., Xu, A., Li, Y., Zhao, S., Zhou, D., Wu, L., Zhang, B., Zhao, X., Wang, Y., Wang, X., et al. (2019) · Liver International

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 29

Meta-analysis of antinuclear antibodies in the diagnosis of antimitochondrial antibody-negative primary biliary cholangitis

Zhang, Q., Liu, Z., Wu, S., Duan, W., Chen, S., Ou, X., You, H., Kong, Y., & Jia, J. (2019) · Gastroenterology Research and Practice

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 28

A brief review on prognostic models of primary biliary cholangitis

Chen, S., Duan, W., You, H., & Jia, J. (2017) · Hepatology International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 20

Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation

Zhang, W., Wu, W., Zhang, N., Li, H., Sun, Y., Ge, X., Han, H., Chen, S., Xu, A., Komakula, S. S. B., et al. (2025) · Theranostics

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 13

FRI-267 Regional fibrosis progression analysed by digital pathology with artificial intelligence is associated with renal dysfunction

Sun, D.-Q., Shen, J.-Q., Tong, X.-F., Li, Y., Targher, G., Ren, Y., Yuan, H., Byrne, C. D., You, H., & Zheng, M.-H. (2024) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentChronic Kidney Disease and Diabetes

Cited by 1